Competition Between Phenothiazines and BH3 Peptide for the Binding Site of the Antiapoptotic BCL-2 Protein
The study of proteins and mechanisms involved in the apoptosis and new knowledge about cancer's biology are essential for planning new drugs. Tumor cells develop several strategies to gain proliferative advantages, including molecular alterations to evade from apoptosis. Failures in apoptosis c...
Main Authors: | Aline Lagoeiro do Carmo, Fernanda Bettanin, Michell Oliveira Almeida, Simone Queiroz Pantaleão, Tiago Rodrigues, Paula Homem-de-Mello, Kathia Maria Honorio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2020.00235/full |
Similar Items
-
Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling, Death in Head, Neck Squamous Cell Carcinoma Cells
by: Rongxiu Li, et al.
Published: (2007-10-01) -
Direct Inhibition of the Conformational Activation of Pro-Apoptotic BAX by the BH4 Domain Helix of BCL-2
by: Barclay, Lauren Anne
Published: (2014) -
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
by: Jessie Pécot, et al.
Published: (2016-12-01) -
A comparative photostability study of four propyl piperzine-substituted phenothiazines
by: Drummond, Patricia Mary
Published: (1997) -
BH3 mimetics as a strategy to complement anticancer therapies
by: Mariusz Ł. Hartman, et al.
Published: (2012-02-01)